Answer
Intravenous ganciclovir raises didanosine plasma concentrations, with didanosine AUC increasing by 38–67% at ganciclovir doses of 5 and 10 mg/kg/day, so patients should be closely monitored for didanosine toxicity.
Sources for this answer
- Cymevene_500mg_powder-for-concentrate-for-solution-for-infusionNeon Healthcare Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 6Document updated
Sources checked